Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trialJ. Brooks Jackson, Francis Mmiro, Paul Bakaki et al.|The Lancet|2003Cited by 525
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV PreventionMary Glenn Fowler, Lynne Mofenson, Min Qin et al.|New England Journal of Medicine|2016Cited by 348
Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical TrialPatricia M. Flynn, Taha E. Taha, Mae Cababasay et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2017Cited by 219
Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum ComponentPatricia M. Flynn, Taha E. Taha, Mae Cababasay et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2021Cited by 63
Intrapartum and Neonatal Single-Dose Nevirapine Compared With Zidovudine for Prevention of Mother-to-Child Transmission of HIV-1 in Kampala, Uganda: 18-Month Follow Up of the HIVNET 012 Randomized TrialJ. Brooks Jackson, Francis Mmiro, Philippa Musoke et al.|Obstetrical & Gynecological Survey|2004Cited by 50